Published in Biochem Biophys Res Commun on February 29, 1984
Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc Natl Acad Sci U S A (1985) 2.24
Regulation of cell proliferation and differentiation by interferons. Biochem J (1985) 1.75
Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumor cells. EMBO J (1985) 1.46
Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation. Proc Natl Acad Sci U S A (1992) 0.93
Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells. EMBO J (1988) 0.93
Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes. J Virol (1985) 0.92
Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine. Mol Cell Biol (1987) 0.91
Murine gamma interferon inhibits v-mos-induced fibroblast transformation via down regulation of retroviral gene expression. J Virol (1987) 0.84
Gamma interferon regulates long terminal repeat-controlled oncogene expression in transformed mouse fibroblasts at the level of mRNA transcription. J Virol (1988) 0.84
Post-transcriptional regulation of transferrin receptor mRNA by IFN gamma. Nucleic Acids Res (1992) 0.82
Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses. EMBO J (1990) 0.82
Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study. Br J Cancer (1990) 0.81
Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice. J Exp Med (1991) 0.79
Short-term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts. J Virol (1991) 0.78
Temperature-sensitive cellular mutant for expression of mRNA from murine retrovirus. J Virol (1988) 0.77
H-ras localizes to cell nuclei and varies with the cell cycle. Genes Cancer (2011) 0.76
Induction of c-Ha-ras gene expression by double-stranded RNA and interferon requirement. Mol Cell Biol (1990) 0.75
Interferon alfa-2b in the treatment of chronic granulocytic leukemia. Invest New Drugs (1987) 0.75
Mechanism of activation of a human oncogene. Nature (1982) 12.09
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (1991) 7.49
Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A (1981) 5.51
Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives. Proc Natl Acad Sci U S A (1971) 5.31
Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature (1982) 5.08
Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J Virol (1980) 4.91
Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J Virol (1980) 4.63
Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization. J Virol (1979) 3.90
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 3.67
Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci U S A (1982) 3.48
Characterization of a human colon/lung carcinoma oncogene. Nature (1983) 3.26
Replication of semliki forest virus: three forms of viral RNA produced during infection. Proc Natl Acad Sci U S A (1966) 3.23
Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol (1968) 3.04
Functional organization of the Harvey murine sarcoma virus genome. J Virol (1980) 2.46
Cytoplasmic fractions associated with Semliki Forest virus ribonucleic acid replication. J Virol (1967) 2.29
Antiviral activity of interferons. Bacteriol Rev (1977) 2.25
Analysis of arbovirus ribonucleic acid forms by polyacrylamide gel electrophoresis. J Virol (1971) 2.10
Transformation by cloned Harvey murine sarcoma virus DNA: efficiency increased by long terminal repeat DNA. Science (1980) 2.05
Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts. J Virol (1972) 2.00
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Cancer Res (1994) 1.86
Membrane-associated replication complex in arbovirus infection. J Virol (1972) 1.83
Dispersion of the ras family of transforming genes to four different chromosomes in man. Nature (1983) 1.82
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res (1996) 1.82
Role of interferon during viremia. II. Protective action of circulating interferon. J Immunol (1966) 1.76
The epidemiology of childhood psychiatric disorders: prevalence findings from recent studies. J Am Acad Child Adolesc Psychiatry (1990) 1.73
Recombinant human gamma interferon inhibits simian malaria. Infect Immun (1986) 1.71
Interferons with special emphasis on the immune system. Adv Immunol (1983) 1.69
Membrane binding of input arbovirus ribonucleic acid: effect of interferon or cycloheximide. J Virol (1970) 1.66
Inhibition of interferon action by puromycin. J Immunol (1965) 1.65
Protein synthesis directed by an arbovirus. J Virol (1968) 1.63
Recurrent digital ischemia due to thrombosis of the persistent median artery. Plast Reconstr Surg (1997) 1.61
Simian virus 40-specific ribosome-binding proteins induced by a nondefective adenovirus 2-simian virus 40 hybrid. J Virol (1977) 1.59
Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol (2000) 1.55
Lysyl oxidase and rrg messenger RNA. Science (1991) 1.55
Specific membranous structures associated with the replication of group A arboviruses. J Virol (1972) 1.54
A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med (1990) 1.53
Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science (1990) 1.53
Replicative intermediate of an arbovirus. J Virol (1968) 1.51
Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon. Proc Natl Acad Sci U S A (1974) 1.50
Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. J Virol (1975) 1.49
Effect of interferon treatment on interferon production. J Immunol (1966) 1.49
Internal stabilization of autogenous rib cartilage grafts in rhinoplasty: a barrier to cartilage warping. Plast Reconstr Surg (1997) 1.48
Amplification and rearrangement of onc genes in mammalian species. Nature (1982) 1.48
Potentiation of human interferon production by superinduction. J Natl Cancer Inst (1971) 1.47
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci U S A (1982) 1.46
Interferon binding: the first step in establishment of antiviral activity. Science (1967) 1.45
Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther (1999) 1.45
Molecular cloning of the Harvey sarcoma virus circular DNA intermediates. II. Further structural analyses. J Virol (1980) 1.45
Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol (1995) 1.45
Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction. J Immunol (1990) 1.44
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res (1994) 1.39
Caring for severely emotionally disturbed children and youth. Principles for a system of care. Child Today (1988) 1.39
Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue. Proc Natl Acad Sci U S A (1983) 1.37
Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res (1993) 1.34
Phase I study of phenylacetate administered twice daily to patients with cancer. Cancer (1995) 1.33
Some factors affecting the interferon-induced antiviral state. Proc Soc Exp Biol Med (1967) 1.33
Structural and nonstructural proteins of an arbovirus. J Virol (1968) 1.33
Interferon inhibits mouse leukaemia virus release: an electron microscope study. J Gen Virol (1977) 1.31
Actinomycin D: inhibition of phospholipid synthesis in chick embryo cells. Science (1968) 1.28
Interferon action on parental Semliki forest virus ribonucleic acid. J Virol (1967) 1.28
Physical, morphological, and biochemical alterations in the membrane of AKR mouse cells after interferon treatment. Proc Natl Acad Sci U S A (1978) 1.23
Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med (2001) 1.21
Restriction of HIV replication in infected T cells and monocytes by interferon-alpha. AIDS Res Hum Retroviruses (1990) 1.21
Primary gene products of an arbovirus. Biochem Biophys Res Commun (1969) 1.20
Regulation of ppp(A2'p)nA-dependent RNase levels during interferon treatment and cell differentiation. Eur J Biochem (1985) 1.19
Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. J Urol (1993) 1.19
Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J Control Release (2001) 1.18
Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med (1983) 1.18
Analysis of the fusion of XC cells induced by homogenates of murine leukemia virus-infected cells and by purified murine leukemia virus. J Virol (1971) 1.17
Inhibition by interferon of production of double-stranded Semliki forest virus ribonucleic acid. Nature (1965) 1.16
Lateral crural strut graft: technique and clinical applications in rhinoplasty. Plast Reconstr Surg (1997) 1.16
A mouse cell line, which is unprotected by interferon against lytic virus infection, lacks ribonuclease F activity. Eur J Biochem (1981) 1.16
The effect of interferon on de novo infection of Moloney murine leukemia virus. Cell (1977) 1.16
Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. Proc Natl Acad Sci U S A (1976) 1.14
Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures. J Virol (1991) 1.14
Inhibition of arbovirus protein synthesis by interferon. J Virol (1968) 1.12
Infrequent RAS oncogene mutations in human prostate cancer. Prostate (1992) 1.10
Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence. J Gen Virol (1981) 1.10
Interferon-induced synthesis of 2-5A-dependent RNase in mouse JLS-V9R cells. Virology (1983) 1.10
Stimulation of interferon production in human lymphocytes by mitogens. Proc Soc Exp Biol Med (1967) 1.09
Interferon-induced alterations in cells: relevance to viral and nonviral diseases. Lab Invest (1983) 1.09
Fine-scale organization of SI (area 3b) in the squirrel monkey revealed with intrinsic optical imaging. J Neurophysiol (2001) 1.09
A novel human cDNA with a predicted protein similar to lysyl oxidase maps to chromosome 15q24-q25. J Biol Chem (1993) 1.08
Basis for variable response of arboviruses to guanidine treatment. J Virol (1970) 1.07
A critical band filter in touch. J Neurosci (1995) 1.06
Encoding of shape and orientation of objects indented into the monkey fingerpad by populations of slowly and rapidly adapting mechanoreceptors. J Neurophysiol (1998) 1.06
Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther (1997) 1.06
Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res (1993) 1.05
Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis. Leukemia (1999) 1.05
Relationships of the structure and function of the interferon receptor to hormone receptors and establishment of the antiviral state. Cancer Res (1978) 1.04
Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes. Restricted antiviral activity of the HIV-induced IFN. J Immunol (1992) 1.03
Inhibition of Protein Synthesis in Cell-Free Systems from Interferon-Treated, Infected Cells: Further Characterization and Effect of Formylmethionyl-tRNA(F). J Virol (1974) 1.02